Oliveira Laura, Timóteo Maria Alexandrina, Correia-de-Sá Paulo
Laboratório de Farmacologia e Neurobiologia, Unidade Multidisciplinar de Investigação Biomédica (UMIB), Instituto de Ciências Biomédicas de Abel Salazar (ICBAS) - Universidade do Porto, L. Prof. Abel Salazar, 2, 4099-003 Porto, Portugal.
Neurosci Lett. 2009 Aug 14;459(3):127-31. doi: 10.1016/j.neulet.2009.05.001. Epub 2009 May 7.
At the rat motor nerve terminals, activation of muscarinic M(1) receptors negatively modulates the activity of inhibitory muscarinic M(2) receptors. The present work was designed to investigate if the negative crosstalk between muscarinic M(1) and M(2) autoreceptors involved endogenous adenosine tonically activating A(1) receptors on phrenic motor nerve terminals. The experiments were performed on rat phrenic nerve-hemidiaphragm preparations loaded with [(3)H]-choline (2.5 microCi/ml). Selective activation of muscarinic M(1) and adenosine A(1) receptors with 4-(N-[3-clorophenyl]-carbamoyloxy)-2-butyryltrimethylammonium (McN-A-343, 3 microM) and R-N(6)-phenylisopropyladenosine (R-PIA, 100 nM), respectively, significantly attenuated inhibition of evoked [(3)H]-ACh release induced by muscarinic M(2) receptor activation with oxotremorine (10 microM). Attenuation of the inhibitory effect of oxotremorine (10 microM) by R-PIA (100 nM) was detected even in the presence of pirenzepine (1 nM) blocking M(1) autoreceptors, suggesting that suppression of M(2)-inhibiton by A(1) receptor activation is independent on muscarinic M(1) receptor activity. Conversely, the negative crosstalk between M(1) and M(2) autoreceptors seems to involve endogenous adenosine tonically activating A(1) receptors. This was suggested, since attenuation of the inhibitory effect of oxotremorine (10 microM) by McN-A-343 (3 microM) was suppressed by the A(1) receptor antagonist, 1,3-dipropyl-8-cyclopentylxanthine (2.5 nM), and by reducing extracellular adenosine with adenosine deaminase (0.5 U/mL) or with the adenosine transport blocker, S-(p-nitrobenzyl)-6-thioinosine (NBTI, 10 microM). The results suggest that the negative crosstalk between muscarinic M(1) and M(2) autoreceptors involves endogenous adenosine outflow via NBTI-sensitive (es) nucleoside transport system channelling to the activation of presynaptic inhibitory A(1) receptors at the rat motor endplate.
在大鼠运动神经末梢,毒蕈碱型M(1)受体的激活对抑制性毒蕈碱型M(2)受体的活性产生负向调节作用。本研究旨在探究毒蕈碱型M(1)和M(2)自身受体之间的负向相互作用是否涉及内源性腺苷持续激活膈运动神经末梢上的A(1)受体。实验在装载有[(3)H]-胆碱(2.5微居里/毫升)的大鼠膈神经-半膈肌标本上进行。分别用4-(N-[3-氯苯基]-氨甲酰氧基)-2-丁酰基三甲基铵(McN-A-343,3微摩尔)和R-N(6)-苯基异丙基腺苷(R-PIA,100纳摩尔)选择性激活毒蕈碱型M(1)受体和腺苷A(1)受体,可显著减弱毒蕈碱型M(2)受体激动剂氧化震颤素(10微摩尔)诱导的诱发[(3)H]-乙酰胆碱释放的抑制作用。即使存在阻断M(1)自身受体的哌仑西平(1纳摩尔),R-PIA(100纳摩尔)仍能减弱氧化震颤素(10微摩尔)的抑制作用,这表明A(1)受体激活对M(2)抑制作用的抑制不依赖于毒蕈碱型M(1)受体的活性。相反,M(1)和M(2)自身受体之间负向相互作用似乎涉及内源性腺苷持续激活A(1)受体。这一点得到了如下证据的支持:A(1)受体拮抗剂1,3-二丙基-8-环戊基黄嘌呤(2.5纳摩尔)以及用腺苷脱氨酶(0.5单位/毫升)或腺苷转运阻滞剂S-(对硝基苄基)-6-硫代次黄嘌呤核苷(NBTI,10微摩尔)降低细胞外腺苷,均可抑制McN-A-343(3微摩尔)对氧化震颤素(10微摩尔)抑制作用的减弱。结果表明,毒蕈碱型M(1)和M(2)自身受体之间的负向相互作用涉及内源性腺苷通过对NBTI敏感的核苷转运系统流出,进而激活大鼠运动终板处的突触前抑制性A(1)受体。